Emergence of MERS-CoV in the Middle East: Origins, Transmission, Treatment, and Perspectives

1. ZakiAM, Van BoheemenS, BestebroerTM, OsterhausAD, FouchierRA (2012) Isolation of a novel coronavirus from a man with pneumonia in saudi arabia. N Engl J Med 367 : 1814–1820 doi:10.1056/NEJMoa1211721

2. RajVS, OsterhausAD, FouchierRA, HaagmansBL (2014) MERS: Emergence of a novel human coronavirus. Curr Opin Virol 5 : 58–62 doi:10.1016/j.coviro.2014.01.010

3. World Health Organization (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update as of 26 June 2014. Available: http://www.who.int/csr/don/2014_06_26_mers/en/. Accessed 30 June 2014.

4. DrostenC, GüntherS, PreiserW, Van Der WerfS, BrodtH, et al. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348 : 1967–1976 doi:10.1056/NEJMoa030747

5. World Health Organization (2003) Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). Available: http://www.who.int/csr/sars/en/WHOconsensus.pdf. Accessed 29 June 2014.

6. van BoheemenS, de GraafM, LauberC, BestebroerTM, RajVS, et al. (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3: e00473–12 doi:10.1128/mBio.00473-12

7. RajVS, MouH, SmitsSL, DekkersDH, MüllerMA, et al. (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495 : 251–254 doi:10.1038/nature12005

8. CormanVM, JoresJ, MeyerB, YounanM, LiljanderA, et al. (2014) Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013. Emerg Infect Dis 20 : 1319–1322 doi:10.3201/eid2008.140596

9. EckerleI, CormanVM, MullerMA, LenkM, UlrichRG, et al. (2014) Replicative capacity of MERS coronavirus in livestock cell lines. Emerg Infect Dis 20 : 276–279 doi:10.3201/eid2002.131182

10. ReuskenCB, HaagmansBL, MüllerMA, GutierrezC, GodekeG, et al. (2013) Middle east respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. Lancet Infect Dis 13 : 859–866 doi:10.1016/S1473-3099(13)70164-6

11. Milne-PriceS, MiazgowiczKL, MunsterVJ (2014) The emergence of the Middle East respiratory syndrome coronavirus (MERS-CoV). Pathog Dis 71 : 121–136 doi:10.1111/2049-632X.12166

12. ZumlaAI, MemishZA (2014) Middle east respiratory syndrome coronavirus: Epidemic potential or a storm in a teacup? Eur Respir J 43 : 1243–1248 doi:10.1183/09031936.00227213

13. World Health Organization (2014) Global Alert and Response: Middle East respiratory syndrome coronavirus (MERS-CoV) –⁠ update, 07 May 2014. Available: http://www.who.int/csr/don/2014_05_07_mers_yemen/en/. Accessed 30 Aug 2014.

14. ReuskenC, FaragE, JongesM, GodekeG, El-SayedA, et al. (2014) Middle east respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, qatar, april 2014. Euro Surveill 19: p20829ii Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20829 Accessed 6 November 2014..

15. NowotnyN, KolodziejekJ (2014) Middle east respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill 19 : 15 Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20781 Accessed 6 November 2014..

16. HaagmansBL, Al DhahirySH, ReuskenCB, RajVS, GalianoM, et al. (2014) Middle east respiratory syndrome coronavirus in dromedary camels: An outbreak investigation. Lancet Infect Dis 14 : 140–145 doi:10.1016/S1473-3099(13)70690-X

17. AssiriA, McGeerA, PerlTM, PriceCS, Al RabeeahAA, et al. (2013) Hospital outbreak of middle east respiratory syndrome coronavirus. N Engl J Med 369 : 407–416 doi:10.1056/NEJMoa1306742

18. Breban R, Riou J, Fontanet A (2013) Interhuman transmissibility of middle east respiratory syndrome coronavirus: Estimation of pandemic risk. Lancet 382: : 694–699.doi:10.1016/S0140-6736(13)61492-0

19. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, et al.. (2014) Middle east respiratory syndrome coronavirus: Quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 14: : 50–56. doi:10.1016/S1473-3099(13)70304-9

20. de WitE, RasmussenAL, FalzaranoD, BushmakerT, FeldmannF, et al. (2013) Middle east respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A 110 : 16598–16603 doi:10.1073/pnas.1310744110

21. Center for Disease Control and Prevention CDC (2014). Interim infection control and prevention recommendations for hospitalized patients with MERS-CoV. Available: http://www.cdc.gov/coronavirus/mers/infection-prevention-control.html. Accessed 29 June 2014.

22. Center for Disease Control and Prevention CDC (2014).MERS Case Definition. Available: http://www.cdc.gov/coronavirus/mers/case-def.html. Accessed 29 June 2014.

23. Infectious Diseases Society of America (2014) MERS clinical update from the IDSA. Available: http://www.magnetmail.net/actions/email_web_version.cfm?recipient_id=124961864&message_id=4470910&user_id=IDSociety&group_id=1191715&jobid=18802511. Accessed 29 June 2014.

24. Center for Disease Control and Prevention CDC (2014) MERS clinical Features. Available: http://www.cdc.gov/coronavirus/mers/clinical-features.html. Accessed 29 June 2014.

25. AssiriA, Al-TawfiqJA, Al-RabeeahAA, Al-RabiahFA, Al-HajjarS, et al. (2013) Epidemiological, demographic, and clinical characteristics of 47 cases of middle east respiratory syndrome coronavirus disease from saudi arabia: A descriptive study. Lancet Infect Dis 13 : 752–761 doi:10.1016/S1473-3099(13)70204-4

26. Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, et al.. (2013) Clinical features and viral diagnosis of two cases of infection with middle east respiratory syndrome coronavirus: A report of nosocomial transmission. Lancet 381: : 2265–2272. doi:10.1016/S0140-6736(13)60982-4

27. MemishZA, ZumlaAI, Al-HakeemRF, Al-RabeeahAA, StephensGM (2013) Family cluster of middle east respiratory syndrome coronavirus infections. N Engl J Med 368 : 2487–2494 doi:10.1056/NEJMoa1303729

28. GuberinaH, WitzkeO, TimmJ, DittmerU, MüllerM, et al. (2014) A patient with severe respiratory failure caused by novel human coronavirus. Infection 42 : 203–206 doi:10.1007/s15010-013-0509-9

29. OmraniAS, MatinMA, HaddadQ, Al-NakhliD, MemishZA, et al. (2013) A family cluster of middle east respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis 17: e668–e672 doi:10.1016/j.ijid.2013.07.001

30. Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, et al.. (2013) Clinical features and virological analysis of a case of middle east respiratory syndrome coronavirus infection. Lancet Infect Dis 13: : 745–751. doi:10.1016/S1473-3099(13)70154-3

31. HijawiB, AbdallatM, SayaydehA, AlqasrawiS, HaddadinA, et al. (2013) Novel coronavirus infections in jordan, april 2012: Epidemiological findings from a retrospective investigation. Emhj 19 : 1.

32. MERS Corona map. Available: http://coronamap.com. Accessed 29 June 2014

33. World Health Organization (2014) WHO concludes MERS-CoV mission in Saudi Arabia, May 2014. Available: http://www.emro.who.int/media/news/mers-cov-mission-saudi-arabia.html. Accessed 9 August 2014.

34. HolmesD (2014) MERS-CoV enigma deepens as reported cases surge. The Lancet 383 : 1793 doi:10.1016/S0140-6736(14)60866-7

35. Reusken CB, Messadi L, Feyisa A, Ularamu H, Godeke GJ, et al.. (2014) Geographic distribution of MERS coronavirus among dromedary camels, africa. Emerging Infect Dis 20 : 1370–1374. doi:10.3201/eid2008.140590

36. ChuDK, PoonLL, GomaaMM, ShehataMM, PereraR, et al. (2014) MERS coronaviruses in dromedary camels, egypt. Emerg Infect Dis 20 : 1049–1053 doi http://dx.doi.org/10.3201/eid2006.140299.

37. World Health Organization (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update as of 20 Jan 2014. Available: http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_Update_20_Jan_2014.pdf. Accessed 29 June 2014.

38. Memish ZA, Assiri A, Almasri M, Alhakeem RF, Turkestani A, et al.. (2014) Prevalence of MERS-CoV nasal carriage and compliance with the saudi health recommendations among pilgrims attending the 2013 hajj. J Infect Dis 210: : 1067–1072. doi:10.1093/infdis/jiu150

39. Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, et al.. (2014) Lack of MERS coronavirus but prevalence of influenza virus in french pilgrims after 2013 hajj. Emerg Infect Dis 20: : 728–730. doi:10.3201/eid2004.131708

40. ZhouN, ZhangY, ZhangJ, FengL, BaoJ (2014) The receptor binding domain of MERS-CoV: The dawn of vaccine and treatment development. J Formosan Med Assoc 113 : 143–147 doi:10.1016/j.jfma.2013.11.006

41. YangX, ChenX, BianG, TuJ, XingY, et al. (2014) Proteolytic processing, deubiquitinase and interferon antagonist activities of middle east respiratory syndrome coronavirus papain-like protease. J Gen Virol 95 : 614–626 doi:10.1099/vir.0.059014-0

42. Al-TawfiqJA, MemishZA (2014) What are our pharmacotherapeutic options for MERS-CoV? Expert Rev Clin Pharmacol 7 : 235–238 doi:10.1586/17512433.2014.890515

43. Brown C, Carson G, Chand M, Zambon M (2014) International Severe Acute Respiratory & Emerging Infection Consortium (ISARIC) -⁠ Clinical Decision Making Tool for Treatment of MERS-CoV v.1.1. Available: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139281416. Accessed 29 June 2014.

44. YaoY, BaoL, DengW, XuL, LiF, et al. (2014) An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J Infect Dis 209 : 236–242 doi:10.1093/infdis/jit590

45. Al-TawfiqJA, MomattinH, DibJ, MemishZA (2014) Ribavirin and interferon therapy in patients infected with the middle east respiratory syndrome coronavirus: An observational study. Int J Infect Dis 20 : 42–46 doi:10.1016/j.ijid.2013.12.003

46. DyallJ, ColemanCM, HartBJ, VenkataramanT, HolbrookMR, et al. (2014) Repurposing of clinically developed drugs for treatment of middle east respiratory coronavirus infection. Antimicrob Agents Chemother 58 : 4885–4893 doi:10.1128/AAC.03036-14